MedTrace Logo

Personalized Risk Identification and Management for Arrhythmias and Heart Failure by ECG and MRI

NCT01353131 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 162

Last updated 2018-11-06

No results posted yet for this study

Summary

Prevention of myocardial functional deterioration and sudden cardiac death among individuals of intermediate risk remains one of the most elusive frontiers of contemporary medicine. While most of these individuals are known to have had contact with the medical system, they are frequently not considered to be at high risk until far advanced along one or multiple disease processes leading to irreversible myocardial loss and electric instability. The goal of this proposal is to determine the prognostic power of combining specific measures of ventricular architecture, myocardial structure and electrical function for the early identification of individuals at risk to develop ventricular arrhythmias and progressive myocardial failure leading to severe cardiovascular outcomes and death.

Conditions

  • Inpatients and Outpatients With Routine 12-lead ECG

Sponsors & Collaborators

Principal Investigators

  • Joao AC Lima, MD, PhD · Johns Hopkins University

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-05-31
Primary Completion
2016-09-30
Completion
2016-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01353131 on ClinicalTrials.gov